| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylosuccinate synthase activity | 1.11e-05 | 2 | 67 | 2 | GO:0004019 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 5.17e-05 | 120 | 67 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | cytidine kinase activity | 6.63e-05 | 4 | 67 | 2 | GO:0043771 | |
| GeneOntologyMolecularFunction | uridine kinase activity | 6.63e-05 | 4 | 67 | 2 | GO:0004849 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.06e-04 | 73 | 67 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | nucleoside kinase activity | 3.93e-04 | 9 | 67 | 2 | GO:0019206 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.11e-04 | 196 | 67 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 5.60e-04 | 200 | 67 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 5.84e-04 | 430 | 67 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.96e-04 | 49 | 67 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 7.50e-04 | 53 | 67 | 3 | GO:0016879 | |
| GeneOntologyMolecularFunction | phosphate ion binding | 1.29e-03 | 16 | 67 | 2 | GO:0042301 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.64e-03 | 18 | 67 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.68e-03 | 70 | 67 | 3 | GO:1901618 | |
| GeneOntologyBiologicalProcess | nucleotide salvage | 1.53e-06 | 26 | 68 | 4 | GO:0043173 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate biosynthetic process | 7.33e-06 | 38 | 68 | 4 | GO:0009156 | |
| GeneOntologyBiologicalProcess | cellular metabolic compound salvage | 9.03e-06 | 40 | 68 | 4 | GO:0043094 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate biosynthetic process | 2.05e-05 | 49 | 68 | 4 | GO:0009124 | |
| GeneOntologyBiologicalProcess | CTP salvage | 3.21e-05 | 3 | 68 | 2 | GO:0044211 | |
| GeneOntologyBiologicalProcess | CMP biosynthetic process | 6.40e-05 | 4 | 68 | 2 | GO:0009224 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate metabolic process | 7.08e-05 | 67 | 68 | 4 | GO:0009161 | |
| GeneOntologyBiologicalProcess | UMP salvage | 1.59e-04 | 6 | 68 | 2 | GO:0044206 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide salvage | 1.59e-04 | 6 | 68 | 2 | GO:0032262 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.59e-04 | 6 | 68 | 2 | GO:1904878 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide salvage | 1.59e-04 | 6 | 68 | 2 | GO:0010138 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate metabolic process | 2.05e-04 | 88 | 68 | 4 | GO:0009123 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound salvage | 2.23e-04 | 7 | 68 | 2 | GO:0008655 | |
| GeneOntologyBiologicalProcess | AMP salvage | 2.96e-04 | 8 | 68 | 2 | GO:0044209 | |
| GeneOntologyBiologicalProcess | 'de novo' AMP biosynthetic process | 2.96e-04 | 8 | 68 | 2 | GO:0044208 | |
| GeneOntologyBiologicalProcess | aspartate metabolic process | 3.80e-04 | 9 | 68 | 2 | GO:0006531 | |
| GeneOntologyBiologicalProcess | aspartate family amino acid metabolic process | 5.33e-04 | 48 | 68 | 3 | GO:0009066 | |
| GeneOntologyBiologicalProcess | iris morphogenesis | 5.78e-04 | 11 | 68 | 2 | GO:0061072 | |
| GeneOntologyBiologicalProcess | UMP biosynthetic process | 5.78e-04 | 11 | 68 | 2 | GO:0006222 | |
| GeneOntologyBiologicalProcess | CMP metabolic process | 5.78e-04 | 11 | 68 | 2 | GO:0046035 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS12 CCN4 ADAMTSL1 FCGBP ZAN ADAMTS2 LRRC3B ADAMTS1 WNT2B ADAMTS20 EMILIN3 MUC5B USH2A | 1.95e-07 | 656 | 69 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS12 CCN4 ADAMTSL1 FCGBP ZAN ADAMTS2 LRRC3B ADAMTS1 WNT2B ADAMTS20 EMILIN3 MUC5B USH2A | 2.02e-07 | 658 | 69 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | intercellular canaliculus | 3.81e-04 | 9 | 69 | 2 | GO:0046581 | |
| MousePheno | middle ear effusion | 4.01e-06 | 9 | 52 | 3 | MP:0030410 | |
| MousePheno | abnormal tympanic cavity morphology | 2.63e-05 | 16 | 52 | 3 | MP:0030154 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.22e-08 | 24 | 68 | 5 | IPR013273 | |
| Domain | TSP_1 | 1.07e-07 | 63 | 68 | 6 | PF00090 | |
| Domain | TSP1 | 1.30e-07 | 65 | 68 | 6 | SM00209 | |
| Domain | TSP1_rpt | 1.30e-07 | 65 | 68 | 6 | IPR000884 | |
| Domain | TSP1 | 1.30e-07 | 65 | 68 | 6 | PS50092 | |
| Domain | Peptidase_M12B_N | 2.88e-07 | 39 | 68 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.88e-07 | 39 | 68 | 5 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.28e-07 | 40 | 68 | 5 | PS00427 | |
| Domain | Reprolysin | 3.28e-07 | 40 | 68 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 3.28e-07 | 40 | 68 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.28e-07 | 40 | 68 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 3.28e-07 | 40 | 68 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 3.73e-07 | 41 | 68 | 5 | IPR001762 | |
| Domain | PLAC | 5.98e-07 | 19 | 68 | 4 | PS50900 | |
| Domain | PLAC | 5.98e-07 | 19 | 68 | 4 | IPR010909 | |
| Domain | ADAM_spacer1 | 1.35e-06 | 23 | 68 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.35e-06 | 23 | 68 | 4 | PF05986 | |
| Domain | TIL | 9.92e-06 | 12 | 68 | 3 | PF01826 | |
| Domain | C8 | 9.92e-06 | 12 | 68 | 3 | PF08742 | |
| Domain | VWC | 1.08e-05 | 38 | 68 | 4 | SM00214 | |
| Domain | MetalloPept_cat_dom | 1.14e-05 | 81 | 68 | 5 | IPR024079 | |
| Domain | - | 1.14e-05 | 81 | 68 | 5 | 3.40.390.10 | |
| Domain | Unchr_dom_Cys-rich | 1.29e-05 | 13 | 68 | 3 | IPR014853 | |
| Domain | C8 | 1.29e-05 | 13 | 68 | 3 | SM00832 | |
| Domain | Adenylsucc_synt | 1.31e-05 | 2 | 68 | 2 | SM00788 | |
| Domain | Adenylsucc_synt | 1.31e-05 | 2 | 68 | 2 | PF00709 | |
| Domain | Adenylosuccin_syn_Lys_AS | 1.31e-05 | 2 | 68 | 2 | IPR033128 | |
| Domain | ADENYLOSUCCIN_SYN_2 | 1.31e-05 | 2 | 68 | 2 | PS00513 | |
| Domain | Adenylosuccin_syn_GTP-bd | 1.31e-05 | 2 | 68 | 2 | IPR018220 | |
| Domain | Adenylosuccinate_synthetase | 1.31e-05 | 2 | 68 | 2 | IPR001114 | |
| Domain | ADENYLOSUCCIN_SYN_1 | 1.31e-05 | 2 | 68 | 2 | PS01266 | |
| Domain | VWF_dom | 1.62e-05 | 42 | 68 | 4 | IPR001007 | |
| Domain | TIL_dom | 1.63e-05 | 14 | 68 | 3 | IPR002919 | |
| Domain | VWD | 2.50e-05 | 16 | 68 | 3 | SM00216 | |
| Domain | VWF_type-D | 2.50e-05 | 16 | 68 | 3 | IPR001846 | |
| Domain | VWFD | 2.50e-05 | 16 | 68 | 3 | PS51233 | |
| Domain | VWD | 2.50e-05 | 16 | 68 | 3 | PF00094 | |
| Domain | ZINC_PROTEASE | 2.88e-05 | 98 | 68 | 5 | PS00142 | |
| Domain | TILa | 3.91e-05 | 3 | 68 | 2 | PF12714 | |
| Domain | TILa_dom | 3.91e-05 | 3 | 68 | 2 | IPR025615 | |
| Domain | PRK/URK | 3.91e-05 | 3 | 68 | 2 | IPR006083 | |
| Domain | PRK | 3.91e-05 | 3 | 68 | 2 | PF00485 | |
| Domain | VWC_out | 4.29e-05 | 19 | 68 | 3 | SM00215 | |
| Domain | Uridine_kinase-like | 7.80e-05 | 4 | 68 | 2 | IPR000764 | |
| Domain | EGF | 2.12e-04 | 235 | 68 | 6 | SM00181 | |
| Domain | ZF_UBR | 2.71e-04 | 7 | 68 | 2 | PS51157 | |
| Domain | zf-UBR | 2.71e-04 | 7 | 68 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.71e-04 | 7 | 68 | 2 | IPR003126 | |
| Domain | ZnF_UBR1 | 2.71e-04 | 7 | 68 | 2 | SM00396 | |
| Domain | EGF-like_dom | 2.90e-04 | 249 | 68 | 6 | IPR000742 | |
| Domain | VWFC_1 | 3.02e-04 | 36 | 68 | 3 | PS01208 | |
| Domain | VWFC_2 | 3.55e-04 | 38 | 68 | 3 | PS50184 | |
| Domain | ABC_transporter_CS | 4.79e-04 | 42 | 68 | 3 | IPR017871 | |
| Domain | ABC_tran | 7.10e-04 | 48 | 68 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.10e-04 | 48 | 68 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.54e-04 | 49 | 68 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 8.00e-04 | 50 | 68 | 3 | IPR003439 | |
| Domain | OA_transporter | 8.42e-04 | 12 | 68 | 2 | IPR004156 | |
| Domain | OATP | 8.42e-04 | 12 | 68 | 2 | PF03137 | |
| Domain | PLAC | 1.16e-03 | 14 | 68 | 2 | PF08686 | |
| Domain | Glyco_hormone_CN | 1.33e-03 | 15 | 68 | 2 | IPR006208 | |
| Domain | Cys_knot | 1.33e-03 | 15 | 68 | 2 | PF00007 | |
| Domain | AAA+_ATPase | 1.88e-03 | 144 | 68 | 4 | IPR003593 | |
| Domain | AAA | 1.88e-03 | 144 | 68 | 4 | SM00382 | |
| Domain | CTCK_1 | 1.92e-03 | 18 | 68 | 2 | PS01185 | |
| Domain | EGF_1 | 2.36e-03 | 255 | 68 | 5 | PS00022 | |
| Domain | Growth_fac_rcpt_ | 2.52e-03 | 156 | 68 | 4 | IPR009030 | |
| Domain | CT | 2.88e-03 | 22 | 68 | 2 | SM00041 | |
| Domain | ABC_membrane | 3.42e-03 | 24 | 68 | 2 | PF00664 | |
| Domain | P-loop_NTPase | 3.50e-03 | 848 | 68 | 9 | IPR027417 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.19e-07 | 68 | 49 | 6 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.17e-07 | 39 | 49 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.17e-07 | 39 | 49 | 5 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.99e-06 | 109 | 49 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.21e-06 | 111 | 49 | 6 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.58e-06 | 143 | 49 | 6 | M27275 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.76e-04 | 6 | 49 | 2 | M22078 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.16e-04 | 250 | 49 | 6 | M27554 | |
| Pathway | REACTOME_METABOLISM_OF_NUCLEOTIDES | 3.52e-04 | 97 | 49 | 4 | MM14607 | |
| Pathway | REACTOME_METABOLISM_OF_NUCLEOTIDES | 3.52e-04 | 97 | 49 | 4 | M777 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.73e-04 | 44 | 49 | 3 | M11911 | |
| Pathway | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | 6.38e-04 | 11 | 49 | 2 | M2071 | |
| Pathway | REACTOME_PYRIMIDINE_SALVAGE | 6.38e-04 | 11 | 49 | 2 | M27689 | |
| Pathway | REACTOME_PYRIMIDINE_SALVAGE | 6.38e-04 | 11 | 49 | 2 | MM15422 | |
| Pathway | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | 6.38e-04 | 11 | 49 | 2 | MM15425 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 6.38e-04 | 11 | 49 | 2 | M930 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 7.64e-04 | 12 | 49 | 2 | MM15476 | |
| Pathway | REACTOME_NUCLEOTIDE_BIOSYNTHESIS | 1.05e-03 | 14 | 49 | 2 | M27830 | |
| Pathway | REACTOME_NUCLEOTIDE_BIOSYNTHESIS | 1.05e-03 | 14 | 49 | 2 | MM15551 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 6.94e-09 | 12 | 69 | 4 | 25770910 | |
| Pubmed | 8.83e-09 | 75 | 69 | 6 | 20637190 | ||
| Pubmed | Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice. | 3.88e-06 | 2 | 69 | 2 | 30416103 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31886153 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15077010 | ||
| Pubmed | Molecular cloning and expression of a mouse muscle cDNA encoding adenylosuccinate synthetase. | 3.88e-06 | 2 | 69 | 2 | 1939273 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 35691019 | ||
| Pubmed | ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population. | 3.88e-06 | 2 | 69 | 2 | 23022423 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26735860 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16890614 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27906629 | ||
| Pubmed | Cardiac Nav 1.5 is modulated by ubiquitin protein ligase E3 component n-recognin UBR3 and 6. | 3.88e-06 | 2 | 69 | 2 | 26059563 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12482871 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17264802 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27239701 | ||
| Pubmed | Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis. | 3.88e-06 | 2 | 69 | 2 | 26845599 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30091450 | ||
| Pubmed | Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. | 3.88e-06 | 2 | 69 | 2 | 11306702 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 29992621 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15786719 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19408031 | ||
| Pubmed | Cloning and characterization of the cDNA encoding human adenylosuccinate synthetase. | 3.88e-06 | 2 | 69 | 2 | 1592113 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8308018 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14999697 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16763017 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24366234 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 34942279 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 30190494 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 35894240 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20163776 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 28733223 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22098322 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22990015 | ||
| Pubmed | DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients. | 1.16e-05 | 3 | 69 | 2 | 20414253 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 33915153 | ||
| Pubmed | The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. | 1.16e-05 | 3 | 69 | 2 | 26025392 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 29238877 | ||
| Pubmed | Analysis of gene mutations in children with cholestasis of undefined etiology. | 2.32e-05 | 4 | 69 | 2 | 20683201 | |
| Pubmed | Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa. | 2.32e-05 | 4 | 69 | 2 | 26806561 | |
| Pubmed | ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. | 2.32e-05 | 4 | 69 | 2 | 10094461 | |
| Pubmed | Familial intrahepatic cholestasis: New and wide perspectives. | 2.32e-05 | 4 | 69 | 2 | 31105019 | |
| Pubmed | ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia. | 2.32e-05 | 4 | 69 | 2 | 29135310 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 11831030 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 15159385 | ||
| Pubmed | 5.64e-05 | 674 | 69 | 8 | 37196079 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 29079593 | ||
| Pubmed | Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. | 5.79e-05 | 6 | 69 | 2 | 23940504 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11279518 | ||
| Pubmed | 1.14e-04 | 47 | 69 | 3 | 11208732 | ||
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 31491533 | ||
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 16940173 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 12068294 | ||
| Pubmed | DYRK3 phosphorylates SNAPIN to regulate axonal retrograde transport and neurotransmitter release. | 1.73e-04 | 10 | 69 | 2 | 36585413 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 25134534 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 11167130 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 24349473 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 31938050 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 14579113 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 1574589 | ||
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 38574132 | ||
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 36108118 | ||
| Pubmed | 3.52e-04 | 1116 | 69 | 9 | 31753913 | ||
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 21964024 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 4.01e-04 | 15 | 69 | 2 | 38871984 | |
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 10464288 | ||
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 17694053 | ||
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 22183742 | ||
| Pubmed | Development of a diagnostic genetic test for simplex and autosomal recessive retinitis pigmentosa. | 5.81e-04 | 18 | 69 | 2 | 20591486 | |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 5.92e-04 | 82 | 69 | 3 | 31073041 | |
| Pubmed | 6.49e-04 | 19 | 69 | 2 | 17493606 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 6.60e-04 | 198 | 69 | 4 | 20881960 | |
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 19922873 | ||
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 7.95e-04 | 21 | 69 | 2 | 22959728 | |
| Pubmed | A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. | 8.73e-04 | 22 | 69 | 2 | 19483677 | |
| Pubmed | 8.73e-04 | 22 | 69 | 2 | 12768436 | ||
| Pubmed | Cytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6. | 8.73e-04 | 22 | 69 | 2 | 24981174 | |
| Pubmed | 9.55e-04 | 23 | 69 | 2 | 20159597 | ||
| Pubmed | 9.64e-04 | 1285 | 69 | 9 | 35914814 | ||
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 29791855 | ||
| Pubmed | Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. | 1.04e-03 | 24 | 69 | 2 | 15245428 | |
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 23085658 | ||
| Pubmed | 1.08e-03 | 101 | 69 | 3 | 18519826 | ||
| Pubmed | 1.13e-03 | 25 | 69 | 2 | 27483141 | ||
| Pubmed | 1.63e-03 | 30 | 69 | 2 | 22837378 | ||
| Pubmed | 1.69e-03 | 118 | 69 | 3 | 21078624 | ||
| Pubmed | The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. | 1.97e-03 | 33 | 69 | 2 | 9765201 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.28e-07 | 19 | 52 | 4 | 50 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.69e-04 | 7 | 52 | 2 | 785 | |
| GeneFamily | ATP binding cassette subfamily B | 4.39e-04 | 11 | 52 | 2 | 806 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 PCSK5 CCN4 ADAMTSL1 EGF ADAMTS2 ADAMTS1 WNT2B NTN5 ADAMTS20 EMILIN3 MUC5B USH2A ADAM22 | 3.76e-07 | 1026 | 69 | 14 | M5889 |
| Coexpression | NABA_MATRISOME | ADAMTS12 PCSK5 CCN4 ADAMTSL1 EGF ADAMTS2 ADAMTS1 WNT2B NTN5 ADAMTS20 EMILIN3 MUC5B ADAM22 | 1.95e-06 | 1008 | 69 | 13 | MM17056 |
| Coexpression | NABA_ECM_REGULATORS | 3.11e-06 | 238 | 69 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 3.48e-06 | 242 | 69 | 7 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 PCSK5 ADAMTSL1 EGF ADAMTS2 ADAMTS1 WNT2B ADAMTS20 MUC5B ADAM22 | 2.24e-05 | 738 | 69 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 PCSK5 ADAMTSL1 EGF ADAMTS2 ADAMTS1 WNT2B ADAMTS20 MUC5B ADAM22 | 2.60e-05 | 751 | 69 | 10 | M5885 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | CCN4 BNC2 ADAMTSL1 SNCAIP ADAMTS2 LRRC3B SLCO2A1 TRPS1 EMILIN3 SALL4 ZNF784 LHX6 ADAM22 | 5.06e-06 | 967 | 64 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | ADAMTS12 PCSK5 CCN4 PPIG ADAMTSL1 SNCAIP ADAMTS2 TLR2 TRPS1 EMILIN3 ZNF784 LHX6 ADAM22 CREB3L2 | 7.59e-06 | 1166 | 64 | 14 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.63e-06 | 244 | 64 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | ADAMTS12 TCEA2 BNC2 ADAMTSL1 SNCAIP HLA-C ADAMTS2 SLCO2A1 TRPS1 EMILIN3 ADGRE5 LHX6 | 1.05e-05 | 878 | 64 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | TCEA2 BNC2 ZNF672 SNCAIP HLA-C SLCO2A1 TRPS1 EMILIN3 UBR3 ADGRE5 LHX6 | 1.09e-05 | 734 | 64 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 1.32e-05 | 172 | 64 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.48e-05 | 265 | 64 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.95e-05 | 384 | 64 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.52e-05 | 288 | 64 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | CCN4 BNC2 ADAMTSL1 ADAMTS2 LRRC3B SLCO2A1 TRPS1 EMILIN3 NCKAP5 ZNF784 LHX6 ADAM22 | 2.73e-05 | 967 | 64 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CCN4 BNC2 ADAMTSL1 SNCAIP ADAMTS2 SLCO2A1 TRPS1 EMILIN3 ZNF784 LHX6 ADAM22 ITPR1 | 2.87e-05 | 972 | 64 | 12 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | ADAMTS12 PCSK5 TCEA2 CCN4 ADAMTSL1 SNCAIP TLR2 EMILIN3 CUL7 ZNF784 LHX6 ADAM22 CREB3L2 | 3.14e-05 | 1148 | 64 | 13 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | TCEA2 BNC2 SNCAIP HLA-C SLCO2A1 TRPS1 EMILIN3 UBR3 ADGRE5 LHX6 | 5.86e-05 | 726 | 64 | 10 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | TCEA2 BNC2 ZNF672 SNCAIP HLA-C TRPS1 EMILIN3 UBR3 ADGRE5 LHX6 | 6.20e-05 | 731 | 64 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.08e-05 | 596 | 64 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TCEA2 BNC2 PPIG SNCAIP HLA-C SLCO2A1 TRPS1 EMILIN3 ADGRE5 LHX6 | 7.18e-05 | 744 | 64 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 1.04e-04 | 249 | 64 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#3 | 1.22e-04 | 160 | 64 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.24e-04 | 371 | 64 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.33e-04 | 163 | 64 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#4_top-relative-expression-ranked_200 | 1.34e-04 | 33 | 64 | 3 | gudmap_kidney_adult_GlomCapSys_Tie2_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | CCN4 BNC2 ADAMTSL1 ADAMTS2 SLCO2A1 TRPS1 EMILIN3 SALL4 ZNF784 LHX6 ADAM22 | 1.34e-04 | 967 | 64 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | CCN4 BNC2 ADAMTSL1 ADAMTS2 SLCO2A1 TRPS1 EMILIN3 SALL4 ZNF784 LHX6 ADAM22 | 1.35e-04 | 968 | 64 | 11 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.40e-04 | 652 | 64 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.82e-04 | 276 | 64 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.75e-04 | 298 | 64 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.77e-04 | 589 | 64 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.86e-04 | 591 | 64 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.60e-04 | 607 | 64 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.73e-04 | 330 | 64 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 5.83e-04 | 479 | 64 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | BNC2 ADAMTSL1 ADAMTS2 SLCO2A1 TRPS1 EMILIN3 SALL4 NCKAP5 LHX6 ARAP2 | 6.22e-04 | 973 | 64 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | CCN4 BNC2 ADAMTSL1 ADAMTS2 SLCO2A1 TRPS1 EMILIN3 SALL4 ZNF784 LHX6 | 6.47e-04 | 978 | 64 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 6.58e-04 | 489 | 64 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.66e-04 | 642 | 64 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 6.82e-04 | 492 | 64 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.58e-04 | 655 | 64 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.58e-04 | 655 | 64 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K3 | 7.60e-04 | 136 | 64 | 4 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 7.81e-04 | 137 | 64 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | BNC2 ADAMTSL1 ADAMTS2 TRPS1 ADAMTS20 TMPRSS2 EMILIN3 NCKAP5 ARAP2 | 7.90e-04 | 826 | 64 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.99e-04 | 241 | 64 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.45e-04 | 834 | 64 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2 | 1.01e-03 | 147 | 64 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-07 | 184 | 69 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-07 | 184 | 69 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-07 | 184 | 69 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-07 | 185 | 69 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.45e-07 | 186 | 69 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.04e-07 | 190 | 69 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.35e-07 | 192 | 69 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 5.69e-07 | 194 | 69 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.74e-06 | 129 | 69 | 5 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-06 | 163 | 69 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-06 | 163 | 69 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 6.90e-06 | 171 | 69 | 5 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 178 | 69 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.06e-05 | 187 | 69 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 189 | 69 | 5 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 190 | 69 | 5 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 190 | 69 | 5 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.15e-05 | 190 | 69 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 193 | 69 | 5 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.27e-05 | 194 | 69 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.27e-05 | 194 | 69 | 5 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 194 | 69 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 194 | 69 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-05 | 194 | 69 | 5 | e56c6e5c9b7d287ae94566b561e21cec2055f83d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 195 | 69 | 5 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 195 | 69 | 5 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.30e-05 | 195 | 69 | 5 | 85fee07d71c0393ea42bcf1130566dff4a62f507 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 195 | 69 | 5 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 195 | 69 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 195 | 69 | 5 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 197 | 69 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | (0)_NK_FCGR3Apos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.40e-05 | 198 | 69 | 5 | 13f10f9233fc1523f0da2d9d59f3ced9c51a603a | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 69 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 200 | 69 | 5 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.52e-05 | 119 | 69 | 4 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.52e-05 | 119 | 69 | 4 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.93e-05 | 136 | 69 | 4 | 5e209185b5f6e9347829fc9066f0b2c3711df057 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-04 | 159 | 69 | 4 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 166 | 69 | 4 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 168 | 69 | 4 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 169 | 69 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 170 | 69 | 4 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 170 | 69 | 4 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 170 | 69 | 4 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.47e-04 | 172 | 69 | 4 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | ILEUM-inflamed-(1)_T_(gd)|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.50e-04 | 173 | 69 | 4 | 85c3e227c81c6ab70148639381389fba3ac5e088 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 175 | 69 | 4 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 175 | 69 | 4 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 69 | 4 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 175 | 69 | 4 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 175 | 69 | 4 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 176 | 69 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.60e-04 | 176 | 69 | 4 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 176 | 69 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.68e-04 | 178 | 69 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 179 | 69 | 4 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 179 | 69 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 179 | 69 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 180 | 69 | 4 | a0faed4cf23f6d5e6e8f6b0284cea8a5bd0680a0 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-04 | 180 | 69 | 4 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 181 | 69 | 4 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | Club-club-8|World / Class top | 1.82e-04 | 182 | 69 | 4 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 182 | 69 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 182 | 69 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 183 | 69 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 183 | 69 | 4 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 184 | 69 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.94e-04 | 185 | 69 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.94e-04 | 185 | 69 | 4 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 185 | 69 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Club|World / Class top | 1.94e-04 | 185 | 69 | 4 | c3caf789e622ed515d143dc594158d52fdcffaef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 185 | 69 | 4 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 185 | 69 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 186 | 69 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 186 | 69 | 4 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 186 | 69 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.98e-04 | 186 | 69 | 4 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 186 | 69 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 186 | 69 | 4 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 187 | 69 | 4 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.02e-04 | 187 | 69 | 4 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.02e-04 | 187 | 69 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.02e-04 | 187 | 69 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.02e-04 | 187 | 69 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-04 | 188 | 69 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-04 | 188 | 69 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-04 | 188 | 69 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 188 | 69 | 4 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 188 | 69 | 4 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 188 | 69 | 4 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-04 | 189 | 69 | 4 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.11e-04 | 189 | 69 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 189 | 69 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-04 | 189 | 69 | 4 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 189 | 69 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| Drug | NcAg | 4.84e-07 | 6 | 67 | 3 | CID002795122 | |
| Drug | 6-azauridine | 1.33e-06 | 28 | 67 | 4 | CID000005901 | |
| Drug | Sparfosate | 2.03e-06 | 31 | 67 | 4 | CID000004312 | |
| Drug | AC1L7UE9 | 8.53e-06 | 2 | 67 | 2 | CID000341622 | |
| Drug | benziodarone | 8.53e-06 | 2 | 67 | 2 | ctd:C058702 | |
| Drug | AC1LAPI9 | 8.53e-06 | 2 | 67 | 2 | CID000472615 | |
| Drug | tasosartan | 8.53e-06 | 2 | 67 | 2 | ctd:C086167 | |
| Drug | tipranavir | 8.53e-06 | 2 | 67 | 2 | ctd:C107201 | |
| Drug | 1-[butoxy(phenyl)methyl]piperidine | 8.53e-06 | 2 | 67 | 2 | CID000219169 | |
| Drug | AC1Q6S1T | 1.31e-05 | 49 | 67 | 4 | CID000000644 | |
| Drug | AC1L1BJ2 | 1.54e-05 | 51 | 67 | 4 | CID000001460 | |
| Drug | glutarimide | 1.61e-05 | 17 | 67 | 3 | CID000070726 | |
| Drug | Primaquine | 1.93e-05 | 18 | 67 | 3 | ctd:D011319 | |
| Drug | alanosyl-AICOR | 2.55e-05 | 3 | 67 | 2 | CID000127520 | |
| Drug | phosphohydantocidin | 2.55e-05 | 3 | 67 | 2 | CID000446561 | |
| Drug | N-ethylglutamine | 2.68e-05 | 20 | 67 | 3 | CID000228398 | |
| Drug | estradiol-17 beta-glucuronide | 3.60e-05 | 22 | 67 | 3 | ctd:C025483 | |
| Drug | thioinosinic acid | 4.14e-05 | 23 | 67 | 3 | CID003034391 | |
| Drug | guanidinosuccinic acid | 4.14e-05 | 23 | 67 | 3 | CID000097856 | |
| Drug | 6-methoxypurine arabinoside | 4.72e-05 | 24 | 67 | 3 | CID000124757 | |
| Drug | CPE-CTP | 5.10e-05 | 4 | 67 | 2 | CID000164056 | |
| Drug | fipexide | 5.10e-05 | 4 | 67 | 2 | ctd:C038628 | |
| Drug | TPPR-MP | 5.10e-05 | 4 | 67 | 2 | CID003036186 | |
| Drug | EUrd | 5.10e-05 | 4 | 67 | 2 | CID000176869 | |
| Drug | streptovitacin A | 5.10e-05 | 4 | 67 | 2 | CID000091467 | |
| Drug | latanoprost | 5.10e-05 | 4 | 67 | 2 | ctd:C072042 | |
| Drug | 3-cyano-2,6-dihydroxypyridine | 8.48e-05 | 5 | 67 | 2 | CID000100608 | |
| Drug | 5-mercaptodeoxyuridine | 8.48e-05 | 5 | 67 | 2 | CID000099529 | |
| Drug | epiallopregnanolone sulfate | 8.48e-05 | 5 | 67 | 2 | ctd:C579439 | |
| Drug | 17beta-estradiol glucuronide | 1.14e-04 | 32 | 67 | 3 | CID000066424 | |
| Drug | 2,5-dibenzylidenecyclopentanone | 1.27e-04 | 6 | 67 | 2 | CID000098039 | |
| Drug | uridine analog | 1.27e-04 | 6 | 67 | 2 | CID000473560 | |
| Drug | HPPR -MP | 1.27e-04 | 6 | 67 | 2 | CID000086479 | |
| Drug | cyclopentenyl uracil | 1.27e-04 | 6 | 67 | 2 | CID000128937 | |
| Drug | thioinosine | 1.49e-04 | 35 | 67 | 3 | CID000676166 | |
| Drug | 5-benzyloxybenzyluracil | 1.77e-04 | 7 | 67 | 2 | CID000099314 | |
| Drug | BBAU | 1.77e-04 | 7 | 67 | 2 | CID000134111 | |
| Drug | Indocyanine Green | 1.77e-04 | 7 | 67 | 2 | ctd:D007208 | |
| Drug | hydantocidin | 1.77e-04 | 7 | 67 | 2 | CID000125429 | |
| Drug | cimetidine | 1.85e-04 | 179 | 67 | 5 | CID000002756 | |
| Drug | CaLam | 2.06e-04 | 39 | 67 | 3 | CID004126474 | |
| Drug | Gabrene | 2.23e-04 | 40 | 67 | 3 | CID005361323 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.27e-04 | 187 | 67 | 5 | 6978_UP | |
| Drug | T beta-MC | 2.36e-04 | 8 | 67 | 2 | CID000168408 | |
| Drug | N3UDP | 2.36e-04 | 8 | 67 | 2 | CID000169817 | |
| Drug | L-alanosine | 2.40e-04 | 41 | 67 | 3 | CID000022128 | |
| Drug | TTNPB; Up 200; 0.1uM; MCF7; HG-U133A | 2.44e-04 | 190 | 67 | 5 | 223_UP | |
| Drug | Diclofenac | 2.62e-04 | 570 | 67 | 8 | ctd:D004008 | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 193 | 67 | 5 | 4122_UP | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 5229_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 3855_UP | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 3890_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 2313_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 3471_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 1684_UP | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 6899_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 6311_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 5098_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 3459_UP | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 2249_UP | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 5592_UP | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HG-U133A | 2.95e-04 | 198 | 67 | 5 | 206_UP | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 3882_DN | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 5391_DN | |
| Drug | 5-benzyluracil | 3.03e-04 | 9 | 67 | 2 | CID000236212 | |
| Drug | S 37 | 3.03e-04 | 9 | 67 | 2 | CID000046875 | |
| Drug | N-hydroxyglycine | 3.03e-04 | 9 | 67 | 2 | CID000019070 | |
| Drug | 4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid | 3.03e-04 | 9 | 67 | 2 | ctd:C000598200 | |
| Drug | oxybutynin | 3.03e-04 | 9 | 67 | 2 | ctd:C005419 | |
| Drug | EM-FU | 3.03e-04 | 9 | 67 | 2 | CID000124352 | |
| Drug | WAY-362450 | 3.03e-04 | 9 | 67 | 2 | ctd:C540004 | |
| Drug | Bbb acyclonucleoside | 3.03e-04 | 9 | 67 | 2 | CID003025732 | |
| Disease | body fat distribution | 4.32e-07 | 202 | 68 | 7 | EFO_0004341 | |
| Disease | urinary tract obstruction (implicated_via_orthology) | 5.23e-06 | 2 | 68 | 2 | DOID:5200 (implicated_via_orthology) | |
| Disease | Progressive intrahepatic cholestasis (disorder) | 1.57e-05 | 3 | 68 | 2 | C0268312 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 1.57e-05 | 3 | 68 | 2 | C4551899 | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 1.57e-05 | 3 | 68 | 2 | cv:C1865643 | |
| Disease | sarcoma (biomarker_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:1115 (biomarker_via_orthology) | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 3.13e-05 | 4 | 68 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 3.13e-05 | 4 | 68 | 2 | C4551898 | |
| Disease | Colorectal Neoplasms | 4.36e-05 | 277 | 68 | 6 | C0009404 | |
| Disease | endodermal sinus tumor (is_marker_for) | 5.21e-05 | 5 | 68 | 2 | DOID:1911 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 9.25e-05 | 102 | 68 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | Cholestasis of pregnancy | 1.45e-04 | 8 | 68 | 2 | C0268318 | |
| Disease | Ventricular Septal Defects | 1.45e-04 | 8 | 68 | 2 | C0018818 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.86e-04 | 9 | 68 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 1.86e-04 | 9 | 68 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | age at onset, multiple sclerosis | 2.33e-04 | 10 | 68 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | otitis media (is_marker_for) | 2.33e-04 | 10 | 68 | 2 | DOID:10754 (is_marker_for) | |
| Disease | skin pigmentation measurement | 2.88e-04 | 137 | 68 | 4 | EFO_0007009 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.04e-04 | 139 | 68 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | diffuse plaque measurement | 3.47e-04 | 758 | 68 | 8 | EFO_0010699 | |
| Disease | actinic keratosis | 4.68e-04 | 14 | 68 | 2 | EFO_0002496 | |
| Disease | squamous cell carcinoma | 5.05e-04 | 67 | 68 | 3 | EFO_0000707 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 5.39e-04 | 15 | 68 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | sinusitis (is_marker_for) | 7.82e-04 | 18 | 68 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | skin aging measurement | 8.21e-04 | 181 | 68 | 4 | EFO_0008006 | |
| Disease | basal cell carcinoma | 9.64e-04 | 189 | 68 | 4 | EFO_0004193 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 9.68e-04 | 20 | 68 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Drug toxicity | 9.76e-04 | 84 | 68 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 9.76e-04 | 84 | 68 | 3 | C0041755 | |
| Disease | intraocular pressure measurement | 1.13e-03 | 509 | 68 | 6 | EFO_0004695 | |
| Disease | otitis media (implicated_via_orthology) | 1.17e-03 | 22 | 68 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.57e-03 | 99 | 68 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | pancreatic cancer (is_marker_for) | 1.66e-03 | 101 | 68 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Bone Diseases, Developmental | 1.77e-03 | 27 | 68 | 2 | C0005941 | |
| Disease | FEV/FEC ratio | 1.97e-03 | 1228 | 68 | 9 | EFO_0004713 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTRGLSCKNKTCGTI | 36 | Q9NWW7 | |
| KGSEGTCSCSSKGFS | 1171 | P78363 | |
| SSLSGSNGGIMCNIC | 1026 | Q6ZN30 | |
| EGCQVLGSKNGSTTC | 511 | P48960 | |
| SSKEGTICSGNGVCS | 681 | Q9P0K1 | |
| FVGSSGCGKSTSIQL | 1111 | O95342 | |
| CLSFVGCSTSGTNSG | 216 | Q8WZ64 | |
| CSTSCGLGVSTRISN | 226 | O95388 | |
| DLCSTSCGGGFQKRT | 1481 | P58397 | |
| GVCGGDNSSCKTITG | 711 | P59510 | |
| GSCSRTCGTGVKFRT | 571 | O95450 | |
| LAGGIAGCCAKTTVA | 41 | P16260 | |
| GAVCSCTGGKLSCLG | 771 | Q9HC84 | |
| LSCLGASLQKSTGCA | 781 | Q9HC84 | |
| NIPCGTTGTTCSKAI | 941 | Q9HC84 | |
| CTGTSGGVLVCQTKH | 511 | Q9UHI8 | |
| VCGGNGSTCKKISGS | 716 | Q9UHI8 | |
| LSVAGCGSCLEGSAQ | 136 | Q6PII5 | |
| TLQFLDCICGSTTGG | 2011 | Q14643 | |
| TKPVASVSGQSSGCC | 1011 | Q86Z02 | |
| TACSSSCGGGIQSRA | 386 | Q8N6G6 | |
| GSLVSSTCGVCGKHV | 181 | Q8IY33 | |
| KSSGGKGGSCSQAAC | 336 | P10321 | |
| LTCSSSGTCTTCQKG | 1426 | Q92824 | |
| GKGSACSSTDVLSCI | 1611 | Q14999 | |
| SVPSAGKNICSSCGL | 61 | Q9UPM6 | |
| KGCLCSSSGGLNVTC | 36 | Q96PB8 | |
| SGQTVALVGSSGCGK | 421 | P21439 | |
| RCLCTGEKGTGKSTQ | 41 | Q13427 | |
| VLCSACSGQGGKSGA | 141 | O60884 | |
| VSATGSKGNRTDSCC | 221 | P30532 | |
| GSVLERDGKTCSGCS | 426 | P01133 | |
| STCTVGSAVCVSGQG | 381 | Q86XK2 | |
| SLGCVAVGSSTCQAS | 1241 | Q9Y6R7 | |
| GSLGCVAVGSTTCQA | 2441 | Q9Y6R7 | |
| GGSLGCVAVGSTTCQ | 3641 | Q9Y6R7 | |
| SDNCGGKVLSITGCS | 536 | Q9Y4F3 | |
| GKSFCLSSVGTQTSG | 151 | Q9NWL6 | |
| GGVGKTTCSCSLAVQ | 46 | O43681 | |
| LSSACCGLSSGQKSS | 206 | P60369 | |
| SGCKSACCVTGLGTS | 301 | A8MX34 | |
| TGLSGKLTSRGVCVC | 111 | Q9BU64 | |
| AGTTVLSCGCVSAGS | 421 | Q9HBE5 | |
| SQLQGLSVSGRGSCC | 371 | Q9NT22 | |
| ITFCSKGGDCLTSQT | 261 | Q8IXB1 | |
| GCTRCGKNFSSASAL | 871 | Q9UJQ4 | |
| SRTCKLAGTQTGTCL | 366 | Q70SY1 | |
| LCNSVGCVTSASGAG | 1446 | O75445 | |
| YALQACTSGGCSTSK | 4331 | O75445 | |
| LVACTNGGCTASVSK | 4421 | O75445 | |
| TSSNCTVGGVCTGLG | 271 | Q8N142 | |
| SASLTCTLCSGINVG | 36 | A0A087WSX0 | |
| LKGSSQGSCLIGSSI | 1646 | O14513 | |
| SGQCTCKLGVTGLTC | 291 | Q8WTR8 | |
| CTTINGLSGKACSTG | 181 | Q9Y6H5 | |
| SSNCTVGGVCTGLGM | 271 | P30520 | |
| LETCCSSELKGGGSG | 526 | Q8NCN4 | |
| TVRKSGQCSGCGKTI | 341 | O15091 | |
| NCSCVTGGSASAKTG | 491 | Q92959 | |
| GSGVFCANCLTTKTS | 891 | Q9UHF7 | |
| SKCSNSGIECDSSGT | 111 | O15393 | |
| IGVSGGTASGKSTVC | 26 | Q9HA47 | |
| TCGFAKCTAGVTTLG | 896 | P38935 | |
| CGVCGKCFGKSSTLT | 201 | Q499Z4 | |
| CTCVGIAASKSGNSS | 521 | Q9NYB5 | |
| SCSAVGTGEGSLCSV | 481 | Q9HAV4 | |
| SGGTASGKSSVCAKI | 26 | Q9BZX2 | |
| CSGGASTAGKRSCLN | 1471 | Q6ZT12 | |
| CDSCGKGFSSSTGLI | 326 | Q86WZ6 | |
| TGGTQTDLFTCGKCR | 251 | Q15560 | |
| GRKASSCSTSLSGCQ | 331 | O60765 | |
| ASLSCDRNGICKGSS | 26 | O60603 | |
| RSITNTTVCTKCGGA | 271 | Q15637 | |
| TTVCTKCGGAGHIAS | 276 | Q15637 | |
| AGRVCSKTSKGTDGC | 321 | Q93097 | |
| GQCGTKGDTTALCRS | 1771 | Q9Y493 | |
| CGICGKGFTQSSVLS | 226 | Q8NCA9 |